Capital Market Strategies’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Capital Market Strategies's JNJ Position: Q2 2025 in Review
Capital Market Strategies reduced its Johnson & Johnson (JNJ) stake by 58% in Q2 2025, selling an estimated $672K and leaving 3,224 shares worth $492K. The position accounts for 0.34% of the portfolio, ranked #55.
Capital Market Strategies first reported a position in JNJ in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.53M in Q4 2022. 4,090 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.
- Capital Market Strategies held 3,224 shares of Johnson & Johnson worth $492K as of Q2 2025.
- Capital Market Strategies sold 4,374 Johnson & Johnson shares in Q2 2025, an estimated $672K.
- Johnson & Johnson made up 0.34% of Capital Market Strategies's portfolio in Q2 2025, its #55 holding.
- Capital Market Strategies first reported a position in Johnson & Johnson in Q4 2021 and has held it in 14 quarters since.
- Capital Market Strategies's Johnson & Johnson position peaked at $1.53M in Q4 2022.
- 4,090 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.
Based on Capital Market Strategies's 13F filing for Q2 2025, filed 2 Jul 2025.